| Title |
Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
|
|---|---|
| Published in |
Current Hematologic Malignancy Reports, February 2016
|
| DOI | 10.1007/s11899-016-0309-2 |
| Pubmed ID | |
| Authors |
Lauren Caldemeyer, Michael Dugan, John Edwards, Luke Akard |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 145 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Czechia | 1 | <1% |
| Ghana | 1 | <1% |
| Unknown | 142 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 12% |
| Student > Bachelor | 17 | 12% |
| Student > Ph. D. Student | 16 | 11% |
| Student > Doctoral Student | 15 | 10% |
| Researcher | 14 | 10% |
| Other | 30 | 21% |
| Unknown | 36 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 35% |
| Biochemistry, Genetics and Molecular Biology | 18 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 8% |
| Agricultural and Biological Sciences | 8 | 6% |
| Chemistry | 4 | 3% |
| Other | 12 | 8% |
| Unknown | 40 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#1,836,483
of 25,998,826 outputs
Outputs from Current Hematologic Malignancy Reports
#17
of 454 outputs
Outputs of similar age
#29,045
of 315,585 outputs
Outputs of similar age from Current Hematologic Malignancy Reports
#2
of 13 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 454 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,585 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.